You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

List of Excipients in API metoprolol succinate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing metoprolol succinate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
AstraZeneca Pharmaceuticals LP TOPROL metoprolol succinate 0186-1088 HYPROMELLOSES
AstraZeneca Pharmaceuticals LP TOPROL metoprolol succinate 0186-1088 PARAFFIN
AstraZeneca Pharmaceuticals LP TOPROL metoprolol succinate 0186-1088 POLYETHYLENE GLYCOL 6000
AstraZeneca Pharmaceuticals LP TOPROL metoprolol succinate 0186-1088 SILICON DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing metoprolol succinate

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc metoprolol succinate 0378-4595 CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc metoprolol succinate 0378-4595 ETHYLCELLULOSE
Mylan Pharmaceuticals Inc metoprolol succinate 0378-4595 HYPROMELLOSE
Mylan Pharmaceuticals Inc metoprolol succinate 0378-4595 LACTOSE MONOHYDRATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for metoprolol succinate

Excipient focus: ACETYLTRIBUTYL CITRATE

Excipient focus: ALCOHOL

Excipient focus: CALCIUM STEARATE

Excipient focus: CAPRYLIC/CAPRIC/LAURIC TRIGLYCERIDE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL BEHENATE

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: HYDROGENATED COTTONSEED OIL

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: METHYLCELLULOSE

Excipient focus: METHYLENE CHLORIDE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: PARAFFIN

Excipient focus: POLOXAMER 188

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K15

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SOYBEAN LECITHIN

Excipient focus: STARCH, CORN

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group